A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
39
100

The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Anosheh Afghahi, Allison W Kurian. Curr Treat Options Oncol 2017
17
100

Universal Genetic Testing for All Breast Cancer Patients.
Mehmet Sitki Copur. Oncology (Williston Park) 2019
4
100

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
Pål Møller, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø. Eur J Cancer 2007
82
100

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
100

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Nadine M Tung, Judy C Boughey, Lori J Pierce, Mark E Robson, Isabelle Bedrosian, Jill R Dietz, Anthony Dragun, Judith Balmana Gelpi, Erin W Hofstatter, Claudine J Isaacs,[...]. J Clin Oncol 2020
48
100

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.
Gabriela Es Felix, Camila Abe-Sandes, Taísa Mb Machado-Lopes, Thaís F Bomfim, Rodrigo Santa Cruz Guindalini, Vanessa Catarine Sar Santos, Lorena Meyer, Polyanna C Oliveira, João Cláudio Neiva, Roberto Meyer,[...]. Hum Genome Var 2014
22
100

Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
Simone M Rowley, Lyon Mascarenhas, Lisa Devereux, Na Li, Kaushalya C Amarasinghe, Magnus Zethoven, Jue Er Amanda Lee, Alexandra Lewis, James A Morgan, Sharne Limb,[...]. Genet Med 2019
17
100

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice.
Angela Rosaria Solano, Florencia Cecilia Cardoso, Vanesa Romano, Florencia Perazzo, Carlos Bas, Gonzalo Recondo, Francisco Bernardo Santillan, Eduardo Gonzalez, Eduardo Abalo, María Viniegra,[...]. Oncotarget 2016
15
100

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Ingrid Petroni Ewald, Silvia Liliana Cossio, Edenir Inez Palmero, Manuela Pinheiro, Ivana Lucia de Oliveira Nascimento, Taisa Manuela Bonfim Machado, Kiyoko Abe Sandes, Betânia Toralles, Bernardo Garicochea, Patricia Izetti,[...]. Genet Mol Biol 2016
14
100

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
100

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Maria Isabel Waddington Achatz, Magali Olivier, Florence Le Calvez, Ghyslaine Martel-Planche, Ademar Lopes, Benedito Mauro Rossi, Patricia Ashton-Prolla, Roberto Giugliani, Edenir Inez Palmero, Fernando Regla Vargas,[...]. Cancer Lett 2007
127
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
100

Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
Hideko Yamauchi, Chizuko Nakagawa, Makoto Kobayashi, Yusuke Kobayashi, Toshiki Mano, Seigo Nakamura, Masami Arai. Breast Cancer 2018
5
100

Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
Jennifer Kerkhof, Laila C Schenkel, Jack Reilly, Sheri McRobbie, Erfan Aref-Eshghi, Alan Stuart, C Anthony Rupar, Paul Adams, Robert A Hegele, Hanxin Lin,[...]. J Mol Diagn 2017
66
100

A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.
Ana Rafaela de Souza Timoteo, Ana Élida Menezes Magalhães Gonçalves, Lucas Amadeus Porpino Sales, Betina Menezes Albuquerque, Jorge Estefano Santana de Souza, Patrícia Cristina Pascoto de Moura, Marcos Alberto Arruda de Aquino, Lucymara Fassarela Agnez-Lima, Tirzah Braz Petta Lajus. Breast Cancer Res Treat 2018
8
100


Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Juliana Giacomazzi, Marcia S Graudenz, Cynthia A B T Osorio, Patricia Koehler-Santos, Edenir I Palmero, Marcelo Zagonel-Oliveira, Rodrigo A D Michelli, Cristovam Scapulatempo Neto, Gabriela C Fernandes, Maria Isabel W S Achatz,[...]. PLoS One 2014
33
100

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
Simone da Costa E Silva Carvalho, Nathalia Moreno Cury, Danielle Barbosa Brotto, Luiza Ferreira de Araujo, Reginaldo Cruz Alves Rosa, Lorena Alves Texeira, Jessica Rodrigues Plaça, Adriana Aparecida Marques, Kamila Chagas Peronni, Patricia de Cássia Ruy,[...]. BMC Med Genomics 2020
9
100

The germline mutational landscape of BRCA1 and BRCA2 in Brazil.
Edenir Inêz Palmero, Dirce Maria Carraro, Barbara Alemar, Miguel Angelo Martins Moreira, Ândrea Ribeiro-Dos-Santos, Kiyoko Abe-Sandes, Henrique Campos Reis Galvão, Rui Manuel Reis, Cristiano de Pádua Souza, Natalia Campacci,[...]. Sci Rep 2018
22
100

CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
Jamile Abud, Patricia Koehler-Santos, Patricia Ashton-Prolla, João Carlos Prolla. Arq Gastroenterol 2012
10
100

Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
61
100

MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.
Maegan E Roberts, Sarah A Jackson, Lisa R Susswein, Nur Zeinomar, Xinran Ma, Megan L Marshall, Amy R Stettner, Becky Milewski, Zhixiong Xu, Benjamin D Solomon,[...]. Genet Med 2018
66
100

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
96
100

Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil.
Nilson Moreira Cipriano, Amanda Marques de Brito, Eneida Santos de Oliveira, Fabiana Castro de Faria, Sara Lemos, Angélica Nogueira Rodrigues, Débora de Oliveira Lopes, Luciana Lara Dos Santos. Breast Cancer 2019
5
100


Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil.
Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla. JCO Glob Oncol 2020
3
100

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Di Shao, Shaomin Cheng, Fengming Guo, Changbin Zhu, Yuying Yuan, Kunling Hu, Zhe Wang, Xuan Meng, Xin Jin, Yun Xiong,[...]. Cancer Sci 2020
7
100

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M Moore, Hiltrud Brauch, Angela Cox,[...]. J Natl Cancer Inst 2018
110
100

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.
Edenir I Palmero, Maira Caleffi, Lavínia Schüler-Faccini, Fernanda L Roth, Luciane Kalakun, Cristina Brinkmann Oliveira Netto, Giovana Skonieski, Juliana Giacomazzi, Bernadete Weber, Roberto Giugliani,[...]. Genet Mol Biol 2009
15
100

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Nana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, Judit Horváth, Dieter Niederacher, Norbert Arnold, Silke Kaulfuß, Corinna Ernst, Victoria G Paul, Ellen Honisch,[...]. Breast Cancer Res 2019
14
100

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
208
100

Clinical Cancer Genetics Disparities among Latinos.
Marcia Cruz-Correa, Julyann Pérez-Mayoral, Julie Dutil, Miguel Echenique, Rafael Mosquera, Keila Rivera-Román, Sharee Umpierre, Segundo Rodriguez-Quilichini, Maria Gonzalez-Pons, Myrta I Olivera,[...]. J Genet Couns 2017
16
100

A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
A M Cock-Rada, C A Ossa, H I Garcia, L R Gomez. Fam Cancer 2018
17
100

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
100

Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.
Aung Ko Win, Jeanette C Reece, James G Dowty, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Melissa C Southey, Joanne P Young, Sean P Cleary, Hyeja Kim,[...]. Int J Cancer 2016
48
100

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon,[...]. Cancer Res Treat 2020
7
100

Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
Sandra Bonache, Irene Esteban, Alejandro Moles-Fernández, Anna Tenés, Laura Duran-Lozano, Gemma Montalban, Vanessa Bach, Estela Carrasco, Neus Gadea, Adrià López-Fernández,[...]. J Cancer Res Clin Oncol 2018
27
100


TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
Eriza Cristina Hahn, Camila Matzenbacher Bittar, Fernanda Sales Luis Vianna, Cristina Brinckmann Oliveira Netto, Jorge Villanova Biazús, Rodrigo Cericatto, José Antônio Cavalheiro, Márcia Portela de Melo, Carlos Henrique Menke, Eliane Rabin,[...]. PLoS One 2018
6
100

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
100

Multi-gene Panel Testing in Breast Cancer Management.
Christos Fountzilas, Virginia G Kaklamani. Cancer Treat Res 2018
7
100

A systematic scoping review of the genetic ancestry of the Brazilian population.
Aracele Maria de Souza, Sarah Stela Resende, Taís Nóbrega de Sousa, Cristiana Ferreira Alves de Brito. Genet Mol Biol 2019
17
100

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Beth Crawford, Sophie B Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van 't Veer. Breast Cancer Res Treat 2017
47
100

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Daniele Fanale, Lorena Incorvaia, Clarissa Filorizzo, Marco Bono, Alessia Fiorino, Valentina Calò, Chiara Brando, Lidia Rita Corsini, Nadia Barraco, Giuseppe Badalamenti,[...]. Cancers (Basel) 2020
6
100

Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort.
Kelly Fulk, Holly LaDuca, Mary Helen Black, Dajun Qian, Yuan Tian, Amal Yussuf, Carin Espenschied, Kory Jasperson. Fam Cancer 2019
3
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.